SGLT2 Inhibitors in Management of Severe Hypomagnesemia in Patients Without Diabetes: A Report of 4 Cases

Sodium/glucose cotransporter 2 (SGLT2) inhibitors have demonstrated a class effect in improving serum magnesium levels in patients with diabetes. Additionally, recent reports have shown their promising beneficial effects in the treatment of refractory hypomagnesemia in patients with diabetes. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Chintan V., Hammad, Nour, Bhasin-Chhabra, Bhavna, Rashidi, Arash
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432792/
https://www.ncbi.nlm.nih.gov/pubmed/37602145
http://dx.doi.org/10.1016/j.xkme.2023.100697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432792/
https://www.ncbi.nlm.nih.gov/pubmed/37602145
http://dx.doi.org/10.1016/j.xkme.2023.100697

Ejemplares similares